Correlation and efficacy of TACE combined with lenvatinib plus PD-1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.5841
Abstract: Although the appearance of portal vein tumor thrombus (PVTT) is significantly associated with unfavorable prognosis, there is insufficient evidence to confirm the efficacy and safety of the triple combination of transarterial chemoembolization (TACE), lenvatinib, and… read more here.
Keywords: portal vein; hepatocellular carcinoma; vein tumor; tumor thrombus ... See more keywords
Liver Transplantation After Downstaging of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Using Yttrium‐90 Radioembolization: Pipe Dream or Reality?
Sign Up to like & getrecommendations! Published in 2021 at "Liver Transplantation"
DOI: 10.1002/lt.26302
Abstract: Portal vein tumor thrombosis (PVTT) in patients with hepatocellular carcinoma (HCC) is associated with a poor survival of typically less than 6 months in untreated patients (1). read more here.
Keywords: portal vein; hepatocellular carcinoma; liver transplantation; vein tumor ... See more keywords
Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus.
Sign Up to like & getrecommendations! Published in 2021 at "Annals of hepatology"
DOI: 10.1016/j.aohep.2021.100552
Abstract: INTRODUCTION AND OBJECTIVES Optimal treatment of hepatocellular carcinoma (HCC) involving portal vein tumor thrombus (PVTT) remains controversial. MATERIALS AND METHODS A total of 627 HCC patients with PVTT after initial treatment with one of the… read more here.
Keywords: hepatocellular carcinoma; vein tumor; patients type; portal vein ... See more keywords
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha‐fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Surgery"
DOI: 10.1016/j.surg.2018.06.025
Abstract: Background Progression of portal vein tumor thrombus directly affects the prognosis and treatment for patients with hepatocellular carcinoma; there are no data on the growth velocity of portal vein tumor thrombus. We analyzed the growth… read more here.
Keywords: portal vein; tumor thrombus; vein tumor;
Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies.
Sign Up to like & getrecommendations! Published in 2018 at "Seminars in liver disease"
DOI: 10.1055/s-0038-1666805
Abstract: Portal vein tumor thrombosis (PVTT) commonly occurs in patients with hepatocellular carcinoma (HCC). Patients with PVTT usually have an aggressive disease course, decreased liver function reserve, limited treatment options, higher recurrence rates after treatment, and,… read more here.
Keywords: vein tumor; hepatocellular carcinoma; treatment; management ... See more keywords
Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology Research"
DOI: 10.1111/hepr.12923
Abstract: The Barcelona Clinic Liver Cancer staging system recommends a tyrosine kinase inhibitor (sorafenib) as standard therapy in advanced hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT). Sorafenib has been shown to prolong median… read more here.
Keywords: hepatocellular carcinoma; vein tumor; surgical treatment; treatment ... See more keywords
Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition)
Sign Up to like & getrecommendations! Published in 2019 at "Liver Cancer"
DOI: 10.1159/000503685
Abstract: Portal vein tumor thrombus (PVTT) is very common, and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the Consensus in 2016.… read more here.
Keywords: vein tumor; hepatocellular carcinoma; treatment; consensus ... See more keywords
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)
Sign Up to like & getrecommendations! Published in 2022 at "Liver Cancer"
DOI: 10.1159/000523997
Abstract: Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016… read more here.
Keywords: hepatocellular carcinoma; portal vein; treatment; vein tumor ... See more keywords
Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.15411
Abstract: Portal vein tumor thrombus is a frequent, challenging complication in hepatocellular carcinoma. Hepatocellular carcinoma patients with portal vein tumor thrombus may show worse liver function, less treatment tolerance and worse prognosis than patients without portal… read more here.
Keywords: portal vein; hepatocellular carcinoma; tumor thrombus; vein tumor ... See more keywords
Eastern experience: surgical resection may be the first choice of treatment for selected hepatocellular carcinoma patients with portal vein tumor thrombus
Sign Up to like & getrecommendations! Published in 2017 at "Translational cancer research"
DOI: 10.21037/13573
Abstract: Hepatocellular carcinoma (HCC) is the sixth most common worldwide cancer and has dismal outcomes because of its high morbidity and mortality, particularly in Eastern countries (1,2); however, the morbidity of HCC is increasing in the… read more here.
Keywords: hepatocellular carcinoma; vein tumor; treatment; portal vein ... See more keywords
Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.906498
Abstract: Background This study aims to establish and validate a predictive model based on radiomics features, clinical features, and radiation therapy (RT) dosimetric parameters for overall survival (OS) in hepatocellular carcinoma (HCC) patients treated with RT… read more here.
Keywords: hepatocellular carcinoma; predictive model; radiomics based; portal vein ... See more keywords